Latest News for: mg 08

Edit

Myasthenia Gravis Pipeline 2024: Comprehensive Clinical Trials and Therapies Analysis with Key MOA and ROA ...

GetNews 14 Mar 2025
In December 2024, Cartesian Therapeutics has released updated efficacy and safety findings from its Phase IIb trial evaluating Descartes-08, an mRNA cell therapy candidate for generalized myasthenia gravis (MG).
  • 1
×